← Leaderboards
Eugene M Laska
New York University School Of Medicine
$1,607,774
Attributed
$2,638,037
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $759.3K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,638,037 · 2
By mechanism
R01$2,060,526 · 1
P01$577,511 · 1
Top collaborators
- Carole E Siegel3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Silvia Fossati$5,961,731
- Jennifer S Scherer$962,331
- Yvonne W Lui$6,439,080
- Mengling Liu$4,123,956
- Sohae Chung$1,563,968
Others in their field
Other Emerging Leaders on “Prognostic”
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,263,760
- Nadine Georges Rouphael · Emory University$13,919,512
- Quy Phung · Leidos Biomedical Research, Inc.$12,889,396
- James Dale Berry · Brigham And Women'S Hospital$9,915,782
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
Research focus
PrognosticAlcohol Use DisorderNovel StrategiesResearch Project GrantsMachine LearningSamplingPersonalized MedicineRandom ForestBaseClinical Trial AnalysisRandomized Clinical TrialsClassificationCausal ModelData AnalysesAnalytical MethodData CollectionBiostatistics CoreConfounding Factors (Epidemiology)ComorbidityBiological MarkersConsultationsCost EfficientAlcohol ComorbidityCommunication
Grant awards (8)
Likely responder analysis and tests of model misspecification in randomized controlled trials of treatments for Alcohol Use Disorder$704,318
R01 · FY2024 · AA · contact PI
Likely responder analysis and tests of model misspecification in randomized controlled trials of treatments for Alcohol Use Disorder$733,630
R01 · FY2023 · AA · contact PI
Likely responder analysis and tests of model misspecification in randomized controlled trials of treatments for Alcohol Use Disorder$622,578
R01 · FY2022 · AA · contact PI
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD$136,753
P01 · FY2022 · AA · contact PI
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD$100,578
P01 · FY2021 · AA · contact PI
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD$100,578
P01 · FY2020 · AA · contact PI
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD$108,836
P01 · FY2019 · AA · contact PI
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD$130,766
P01 · FY2018 · AA · contact PI